• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抑制程序性死亡配体1以生物活性为导向合成海洋天然产物纳米丁J及其作为潜在肿瘤免疫药物的衍生物

Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1.

作者信息

Fu Pan-Pan, Wang Qun, Zhang Qing, Jin Yang, Liu Jin, Chen Kai-Xian, Guo Yue-Wei, Liu San-Hong, Li Xu-Wen

机构信息

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.

出版信息

J Med Chem. 2023 Apr 27;66(8):5427-5438. doi: 10.1021/acs.jmedchem.2c01702. Epub 2023 Apr 11.

DOI:10.1021/acs.jmedchem.2c01702
PMID:37040446
Abstract

The total synthesis of the marine natural product naamidine J and a rapid structure modification toward its derivatives were achieved on the basis of several rounds of structure-relationship analyses of their tumor immunological activities. These compounds were tested for programmed death-ligand 1 (PD-L1) protein expression in human colorectal adenocarcinoma RKO cells. Among them, compound was found to efficiently suppress constitutive PD-L1 expression in RKO cells with low toxicity and further exerted its antitumor effect in MC38 tumor-bearing C57BL/6 mice by reducing PD-L1 expression and enhancing tumor-infiltrating T-cell immunity. This research work may provide insight for the discovery of new marine natural product-derived tumor immunological drug leads.

摘要

基于对海洋天然产物那米定J的肿瘤免疫活性进行的几轮构效关系分析,实现了其全合成以及对其衍生物的快速结构修饰。对这些化合物在人结肠腺癌RKO细胞中进行程序性死亡配体1(PD-L1)蛋白表达测试。其中,发现化合物能有效抑制RKO细胞中组成型PD-L1表达,且毒性低,并通过降低PD-L1表达和增强肿瘤浸润性T细胞免疫,在荷MC38肿瘤的C57BL/6小鼠中进一步发挥其抗肿瘤作用。这项研究工作可能为发现新的海洋天然产物衍生的肿瘤免疫药物先导物提供思路。

相似文献

1
Bioactivity-Driven Synthesis of the Marine Natural Product Naamidine J and Its Derivatives as Potential Tumor Immunological Agents by Inhibiting Programmed Death-Ligand 1.通过抑制程序性死亡配体1以生物活性为导向合成海洋天然产物纳米丁J及其作为潜在肿瘤免疫药物的衍生物
J Med Chem. 2023 Apr 27;66(8):5427-5438. doi: 10.1021/acs.jmedchem.2c01702. Epub 2023 Apr 11.
2
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.肿瘤细胞上的程序性死亡配体1(PD-L1)足以在免疫原性肿瘤中实现免疫逃逸,并抑制CD8 T细胞的细胞毒性。
J Exp Med. 2017 Apr 3;214(4):895-904. doi: 10.1084/jem.20160801. Epub 2017 Mar 16.
3
Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.日本血凝病毒-含程序性细胞死亡配体 1 的 siRNA 抑制胶质瘤的免疫抑制活性并引发抗肿瘤免疫反应。
Cancer Sci. 2021 Jan;112(1):81-90. doi: 10.1111/cas.14721. Epub 2020 Nov 25.
4
Antitumor Effect of Korean Red Ginseng through Blockade of PD-1/PD-L1 Interaction in a Humanized PD-L1 Knock-In MC38 Cancer Mouse Model.人参抗肿瘤作用通过阻断人源化 PD-L1 敲入 MC38 肿瘤模型中的 PD-1/PD-L1 相互作用。
Int J Mol Sci. 2023 Jan 18;24(3):1894. doi: 10.3390/ijms24031894.
5
Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma.结直肠癌中PD-L1表达及肿瘤浸润淋巴细胞的免疫分类
BMC Cancer. 2020 Jan 28;20(1):58. doi: 10.1186/s12885-020-6553-9.
6
Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro.程序性细胞死亡受体 1:程序性细胞死亡配体 1 相互作用可保护人心肌细胞免受体外 T 细胞介导的炎症和细胞凋亡反应。
Int J Mol Sci. 2020 Mar 31;21(7):2399. doi: 10.3390/ijms21072399.
7
Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression.联合蛋白精氨酸甲基转移酶抑制剂和抗程序性死亡配体-1 抑制胰腺癌进展。
World J Gastroenterol. 2020 Jul 14;26(26):3737-3749. doi: 10.3748/wjg.v26.i26.3737.
8
Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction.发现 1,3,4-噁二唑衍生物作为潜在的抗肿瘤剂,抑制程序性细胞死亡-1/程序性细胞死亡配体 1 相互作用。
Bioorg Med Chem. 2021 Sep 15;46:116370. doi: 10.1016/j.bmc.2021.116370. Epub 2021 Aug 18.
9
A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with Ga-labeled PD-L1 targeted nanobody.一项临床前研究:PD-L1 PET 成像与 Ga 标记 PD-L1 靶向纳米抗体预测 MC38 肿瘤治疗效果的相关性。
Aging (Albany NY). 2021 Apr 27;13(9):13006-13022. doi: 10.18632/aging.202981.
10
The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.MEK 抑制剂联合靶向程序性死亡受体 1 和程序性死亡配体 1 的免疫调节抗体可延长 Kras/p53 驱动的肺癌患者的生存时间。
J Thorac Oncol. 2019 Jun;14(6):1046-1060. doi: 10.1016/j.jtho.2019.02.004. Epub 2019 Feb 13.

引用本文的文献

1
Imidazole Hybrids: A Privileged Class of Heterocycles in Medicinal Chemistry with New Insights into Anticancer Activity.咪唑杂化物:药物化学中一类重要的杂环化合物,对其抗癌活性有新见解。
Molecules. 2025 May 21;30(10):2245. doi: 10.3390/molecules30102245.
2
Discovery of novel small molecules targeting hepatitis B virus core protein from marine natural products with HiBiT-based high-throughput screening.基于HiBiT的高通量筛选从海洋天然产物中发现靶向乙型肝炎病毒核心蛋白的新型小分子
Acta Pharm Sin B. 2024 Nov;14(11):4914-4933. doi: 10.1016/j.apsb.2024.07.019. Epub 2024 Aug 3.
3
Chemoproteomics of Marine Natural Product Naamidine J Unveils CSE1L as a Therapeutic Target in Acute Lung Injury.
海洋天然产物那米定J的化学蛋白质组学揭示CSE1L是急性肺损伤的治疗靶点。
J Am Chem Soc. 2024 Oct 16;146(41):28384-28397. doi: 10.1021/jacs.4c09695. Epub 2024 Sep 26.
4
Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges.靶向PD-1/PD-L-1免疫检查点抑制用于癌症免疫治疗:成功与挑战
Front Immunol. 2024 Apr 10;15:1383456. doi: 10.3389/fimmu.2024.1383456. eCollection 2024.